Human iPS Cell Line (Episomal, HFF)

Footprint-free human iPS (induced pluripotent stem) cell line was derived from human foreskin fibroblasts (HFFs) by ectopic expression of OCT4, SOX2, KLF4, and c-MYC genes using episomal plasmids.

Human iPS Cell Line (Episomal, MSC)

Footprint-free human iPS (induced pluripotent stem) cell line was derived from human mesenchymal stromal cells (MSCs) by ectopic expression of OCT4, SOX2, KLF4, and c-MYC genes using episomal plasmids.

Human iPS Cell Line (Episomal, PBMC)

Footprint-free human iPS (induced pluripotent stem) cell line was derived from human peripheral blood mononuclear cells (PBMCs) by ectopic expression of OCT4, SOX2, KLF4, and c-MYC genes using episomal plasmids.

Human iPS Cell Line (Episomal, CD34+, ApoE4)

Footprint-free human iPS (induced pluripotent stem) cell line was derived from human bone marrow CD34+ mononuclear cells by ectopic expression of OCT4, SOX2, KLF4, c-MYC and Lin28 genes using episomal plasmids.

Human iPS Cell Line (Episomal, CD34+, ApoE3)

Footprint-free human iPS (induced pluripotent stem) cell line with ApoE3 isoform was derived from human iPSC (cat# iPS16) with ApoE4 isoform by changing Arg112 to Cys112 with genome editing technology.

Human iPS Cell Line (Episomal, CD34+, ApoE Knockout)

Footprint-free human iPS (induced pluripotent stem) cell line with APOE deficient was derived from human iPSC (cat# iPS16) with ApoE4 isoform using genome editing method to introduce a deletion and a frame shift in the exon 2 of APOE gene.

Human iPS Cell Line (Retroviral)

Human iPS (induced pluripotent stem) cell line was derived from human foreskin fibroblasts (HFFs) by retroviral expression of OCT4, SOX2, KLF4, and c-MYC genes.

Mouse iPS Cell Line

Mouse induced pluripotent stem cell line derived using morphological selection criteria and without the use of fluorescent marker or drug selection.

Human Neural Stem Cell Line

Neural Stem Cell Line derived from footprint-free iPS cells. Can differentiate to over 90% of neurons under defined conditions.